ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

(R)-2-(2,4-ジクロロフェノキシ)プロピオン酸

Dichlorprop-P

HCID 119435
ノート反応
基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
15165-67-0
標準SMILES
C[C@@H](Oc1ccc(Cl)cc1Cl)C(=O)O
InChIKey
MZHCENGPTKEIGP-RXMQYKEDSA-N
分子式
C9H8Cl2O3
平均分子量
235.06 g/mol
単同位体質量
233.9850495

名称と識別子

優先名称
Dichlorprop-P
IUPAC
(2R)-2-(2,4-dichlorophenoxy)propanoic acid
現地名
(R)-2-(2,4-ジクロロフェノキシ)プロピオン酸
英語名
(R)-2-(2,4-Dichlorophenoxy)propanoic acid
分子式
C9H8Cl2O3
分子量
235.06

名称と別名

Dichlorprop-P15165-67-0(R)-Dichlorprop(+)-Dichlorprop(2R)-2-(2,4-dichlorophenoxy)propanoic acidOptica DPDichlorprop, D-Dichlorprop-P [ISO:BSI]D-dichlorpropDTXSID0034851UNII-0UD1MQP96O(R)-DCPP
名称をさらに表示
(R)-2-(2,4-ジクロロフェノキシ)プロピオン酸(+)-2-(2,4-ジクロロフェノキシ)プロパン酸(2R)-2-(2,4-ジクロロフェノキシ)プロピオン酸(R)-2-(2,4-ジクロロフェノキシ)プロパン酸ジクロルプロップp(2R)-2-(2,4-ジクロロフェノキシ)プロパン酸(+)-2-(2,4-ジクロロフェノキシ)プロピオン酸ジクロロプロップ-Pジクロルプロップ-P(+)-(R)-2-(2,4-ジクロロフェノキシ)プロパン酸AHM 867DuplosanduplosandpPS44_SUPELCODICHLOROPROP-PD(+)-DICHLORPROP
0UD1MQP96OBRN 3203102CORASILPropanoic acid, 2-(2,4-dichlorophenoxy)-, (R)-Propionic acid, 2-(2,4-dichlorophenoxy)-, (+)-(R)-(+)-dichlorpropDICHLORPROP-P [ISO]DICHLORPROP, (+)-

データベース識別子

CAS
15165-67-0
PubChem CID
119435
DTXSID
DTXSID0034851
ChEMBL
CHEMBL2252703
ChEBI
CHEBI:75373
UNII
0UD1MQP96O
EC Number
403-980-1、604-810-0
Nikkaji
J293.375F

物性

構造計算による物性

XLogP
3.4
極性表面積
46.5 Ų
水素結合供与体数
1
水素結合受容体数
3
回転可能結合数
3
重原子数
14
形式電荷
0
複雑度
210

実験および物理化学的性質

Vapor Pressure0.00000046 [mmHg]
Physical DescriptionWhite solid with naphthalene odor; [Reference #1]

物理化学的性質

融点
124 ° · 124°
比旋光度
21 D · 21D +26.6° (c = 1.23 in ethanol)
沸点
348.3 · 348.3±27.0 °C(Predicted)
比重(密度)
1.421 · 1.421±0.06 g/cm3(Predicted)
闪点
2 °C · 2 °C
貯蔵温度
Sealed in dry,Room Temperature
酸解離定数(Pka)
3.03 · 3.03±0.10(Predicted)
Merck
13 · 13,3104
BRN
5265110 · 5265110
Henry's Law Constant
4 · 4.0×104 mol/(m3Pa) at 25℃, Mackay et al. (2006)
主な用途
農業環境
InChI
InChI=1S/C9H8Cl2O3/c1-5(9(12)13)14-8-3-2-6(10)4-7(8)11/h2-5H,1H3,(H,12,13)/t5-/m1/s1
InChIKey
MZHCENGPTKEIGP-RXMQYKEDSA-N
SMILES
C(O)(=O)[C@H](OC1=CC=C(Cl)C=C1Cl)C

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 6 件

Danger

H302: Harmful if swallowed [Warning Acute toxicity, oral];H315: Causes skin irritation [Warning Skin corrosion/irritation];H317: May cause an allergic skin reaction [Warning Sensitization, Skin];H318: Causes serious eye damage [Danger Serious eye damage/eye irritation]

P261, P264, P264+P265, P270, P272, P280, P301+P317, P302+P352, P305+P354+P338, P317, P321, P330, P332+P317, P333+P317, P362+P364, and P501 (click each P-code to see the statement)

Danger

危険有害性情報

Regulatory Information · 5 件

Commission Regulation No 844/2012

2,4-DP-p + salt & ester is listed in the dataset of EPA Human Health Benchmarks for Pesticides under the Safe Drinking Water Act (40 eCFR 141)

2006/74/EC, Reg. (EU) 2019/168, Reg. (EU) 2018/524, Reg. (EU) 2020/421, Reg. (EU) 2021/566, Reg. (EU) 2022/378, Reg. (EU) 2023/689, Reg. (EU) 2025/99, Reg. (EU) No 1166/2013, Reg. (EU) No 540/2011, Reg. (EU) No 878/2014

Status: Active Update: 10-11-2008 https://echa.europa.eu/registration-dossier/-/registered-dossier/9307

Dichlorprop-p: Does not have an individual approval but may be used under an appropriate group standard

Hazards Summary · 1 件

Risk of serious damage to eyes; A 6-year study of workers handling phenoxy herbicides did not find any adverse effects; Workers had no abnormalities of hemoglobin, liver function tests, or kidney function tests; [European Food Safety Authority (EFSA): Active Substances in Plant Protection Products] See Dichlorprop.

Hazard Classes and Categories · 4 件

Acute Tox. 4 (100%);Skin Irrit. 2 (100%);Skin Sens. 1 (100%);Eye Dam. 1 (100%);Aquatic Acute 1 (50%);Aquatic Chronic 2 (50%)

Acute Tox. 4 (100%);Skin Irrit. 2 (100%);Skin Sens. 1 (100%);Eye Dam. 1 (100%)

Skin irritation - category 2;Eye damage - category 1;Skin sensitisation - category 1;Acute toxicity (ingestion) - category 4

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

CDDs are absorbed through oral, inhalation, and dermal routes of exposure. CDDs are carried in the plasma by serum lipids and lipoproteins, distributing mainly to the liver and adipose tissue. CDDs are very slowly metabolized by the microsomal monooxygenase system to polar metabolites that can undergo conjugation with glucuronic acid and glutathione. They may increase the rate of their own metabolism by inducing CDDs induce both phase I and phase II enzymes. The major routes of excretion of CDDs are the bile and the feces, though smaller amounts are excreted in the urine and via lactation. (L177)

用途と製造

Uses · 2 件

Used as a post-emergence herbicide against broadleaf weeds and brush in ornamental lawns, recreational turf, sod farms, roadsides, industrial sites, rights-of-way, and forests; [Reference #1]

Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)

Use Classification · 2 件

Herbicides, Plant growth regulators

Environmental transformation -> Pesticides (parent, predecessor)

応用分野

使用Herbicide.

上流・下流製品情報

上流原料

(S)-(-)-2-クロロプロピオン酸 メチル2,4-ジクロロフェノール2-(2,4-ジクロロフェノキシ)プロピオン酸

関連反応

2 件
反応記録を作成
HRID 1400243 の反応式
HRID 1400243生成物としてuspto-grants-2014_12
HRID 1586276 の反応式
HRID 1586276反応物としてuspto-grants-1999_08

化合物ノート

読み込み中…

このページの内容基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
LogP
2.78 · 2.780 (est)
EPAの化学物質情報
(R)-Dichlorprop (15165-67-0)

Acute Tox. 4 *;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1

毒性情報

TreatmentTreatment may include washing any areas of contact, GI decontamination if swallowed, administering an IV and forced alkaline diuresis. (L346)
Health Effects · 1 件

It is considered to be a severe eye irritant. There has been concern that chlorophenoxy herbicides including dichlorprop may cause cancer, and in 1987 the International Agency for Research on Cancer (IARC) ranked this class of compounds as group 2B "possibly carcinogenic to humans". The EPA classifies the R-isomer as “Not Likely to be Carcinogenic to Humans.”(L369) Exposure to large amounts of CDDs causes chloracne, a severe skin disease with acne-like lesions that occur mainly on the face and upper body. CDDs may also cause liver damage and induce long-term alterations in glucose metabolism and subtle changes in hormonal levels. In addition, studies have shown that CDDs may disrupt the endocrine system and weaken the immune system, as well as cause reproductive damage and birth defects, central and peripheral nervous system pathology, thyroid disorders, endometriosis, and diabetes. 2,3,7,8-Tetrachlorodibenzo-p-dioxin is also a known human carcinogen. (L177, L178)

Adverse EffectsOccupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
Toxicity Summary · 1 件

CDDs cause their toxic effects by binding to the aryl hydrocarbon receptor and subsequently altering the trascription of certain genes. The affinity for the Ah receptor depends on the structure of the specific CDD. The change in gene expression may result from the direct interaction of the Ah receptor and its heterodimer-forming partner, the aryl hydrocarbon receptor nuclear translocator, with gene regulatory elements or the initiation of a phosphorylation/dephosphorylation cascade that subsequently activates other transcription factors. The affected genes include several oncogenes, growth factors, receptors, hormones, and drug-metabolizing enzymes. The change in transcription/translation of these genes is believed to be the cause of most of the toxic effects of CDDs. This includes 2,3,7,8-tetrachlorodibenzo-p-dioxin's carcinogenicity is thought to be the result of its ability to alter the capacity of both exogenous and endogenous substances to damage the DNA by inducing CYP1A1- and CYP1A2-dependent drug-metabolizing enzymes. (L177)

Signs and SymptomsIn addition to chloracne, CDD exposure causes skin rashes, discoloration, and excessive body hair. (L177)
Carcinogen Classification2B, possibly carcinogenic to humans. (L135)
Toxicity Data · 2 件

LC50 (rat) >2700 mg/m3

LD50: 344 mg/kg (Oral, Rat)

RAIS Toxicity Values · 4 件

1.25

OPP

0.06

OPP

EPA Human Health Benchmarks for Pesticides · 6 件

2,4-DP-p + salt & ester

1.25

8330

Children

0.06

400

法規制情報

Regulatory Information · 5 件

Commission Regulation No 844/2012

2,4-DP-p + salt & ester is listed in the dataset of EPA Human Health Benchmarks for Pesticides under the Safe Drinking Water Act (40 eCFR 141)

2006/74/EC, Reg. (EU) 2019/168, Reg. (EU) 2018/524, Reg. (EU) 2020/421, Reg. (EU) 2021/566, Reg. (EU) 2022/378, Reg. (EU) 2023/689, Reg. (EU) 2025/99, Reg. (EU) No 1166/2013, Reg. (EU) No 540/2011, Reg. (EU) No 878/2014

Status: Active Update: 10-11-2008 https://echa.europa.eu/registration-dossier/-/registered-dossier/9307

Dichlorprop-p: Does not have an individual approval but may be used under an appropriate group standard

安全データ

wgk
1
rtecs
UA2458860
ridadr
UN1648 3/PG 2
risk_code
22-38-41-43-36-20/21/22-11
hazard_code
Xn,F
safety_code
24-26-37/39-36-16-36/37
Hazard Classifications
Acute Tox. 4 OralEye Dam. 1Skin Irrit. 2Skin Sens. 1
ストレージクラス
11 - Combustible Solids
プロピオン酸 ナトリウム

サプライヤー62 社

上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
上海凌富药物研究有限公司+86(21)5895 0110 19945755304 · [email protected]
湖北威德利化学试剂有限公司186-02735115 18062128043 · [email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
杭州品高化工有限公司0571-87658025 · [email protected]
杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
陕西缔都化学有限公司029-029-81123119 17391733320 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
山东利腾生物科技有限公司+86-18663721413 +86-15552573001 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
山东沃德森生物科技有限公司0531-88723173 18596073690 · [email protected]
湖南汇百侍生物科技有限公司0731-85526065 13308475853 · [email protected]
上海遐瑞医药科技有限公司+86 21 61551611
成都创科诚生物科技有限公司028-028-0000000 13008177686 · [email protected]
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
天津阿尔塔科技有限公司022-65378550-8551 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 · [email protected]
天津阿尔塔科技有限公司022-6537-8550 15522853686 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
HANGZHOU LEAP CHEM CO., LTD.+86-571-87711850 +86-15355479329 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
济南泰恒生物科技有限公司17852565707 · [email protected]
湖北万业众诚化学试剂有限责任公司18671296875 · [email protected]
上海西陇生化科技有限公司021-52907766-8042
上海源叶生物科技有限公司18916372613 · [email protected]
山东西亚化学有限公司4009903999 13395398332 · [email protected]
成都华纯科技有限公司400-1166-196 15982826727 · [email protected]
郑州艾克姆化工有限公司0371-0371-55629727 13323845623 · [email protected]
郑州汇聚化工有限公司0371-55900031 18137872243 · [email protected]
Shanghai Acmec Biochemical Technology Co., Ltd.+86-18621343501 · [email protected]
北京索莱宝科技有限公司010-50973130 17801761073 · [email protected]
杭州洁汉化工有限公司+86-571-86217390; +8618058761490 · [email protected]
上海百舜生物科技有限公司021-37581181 · [email protected]
深圳市丽晶生化科技有限公司0755-85201366 18938635012 · [email protected]
江苏艾康生物医药研发有限公司025-58859352 19370895928 · [email protected]
上海吉至生化科技有限公司021-4009004166/18616739031 18616739031 · [email protected]
北京迈瑞达科技有限公司010-82387566 18001021521 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
深圳利斯康医药科技有限公司+86-755-89396905 +86-15013857715 · [email protected]
Aladdin Scientific[email protected]
湖北达豪化工有限公司027-59106191 13986034860 · [email protected]
爆牛贸易重庆有限公司+86-023-6139-8061 +86-86-13650506873 · [email protected]
湖北信康医药化工有限公司027-027-59308705 18871579363 · [email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD.+8618950047208 · [email protected]
湖北拓邦化工有限公司027-59106185 13986192185 · [email protected]
SHANGHAI KEAN TECHNOLOGY CO., LTD.+8613817748580 · [email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 18012923235 · [email protected]
常州英飒医药科技有限公司15151934985 · [email protected]

補足説明

定義ChEBI: The R- (active) enantiomer of dichlorprop. It is used as a herbicide for killing annual and broad leaf weeds.